1 study found for:    21631324 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma
Conditions: Recurrent Melanoma;   Stage IIIA Melanoma;   Stage IIIB Melanoma;   Stage IIIC Melanoma;   Stage IV Melanoma
Interventions: Biological: aldesleukin;   Biological: gp100 antigen;   Drug: Montanide ISA 51 VG;   Procedure: quality-of-life assessment;   Other: questionnaire administration;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years